During the past decade, Moffitt Cancer Center-International Plaza conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 2 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moffitt Cancer Center-International Plaza" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moffitt Cancer Center-International Plaza" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Moffitt Cancer Center-International Plaza" are "Stage IV Lung Cancer AJCC v8" (5 trials), "Metastatic Malignant Solid Neoplasm" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials) and "Stage IVA Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Moffitt Cancer Center-International Plaza" in a lesser frequency.

Most popular intervention types in "Moffitt Cancer Center-International Plaza" are "Drug" (34 trials), "Other" (26 trials), "Biological" (24 trials), "Procedure" (18 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Nivolumab" (13 trials), "Biospecimen Collection" (12 trials), "Computed Tomography" (11 trials) and "Questionnaire Administration" (11 trials). Other intervention names were less common.

The vast majority of trials in "Moffitt Cancer Center-International Plaza" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Moffitt Cancer Center-International Plaza". undefined are not yet recruiting, 19 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Moffitt Cancer Center-International Plaza, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Moffitt Cancer Center-International Plaza, 7 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".